(Q24186580)

30 June 2019

meta-analysis

0 references

review article

1 reference

title

Pharmacological treatment for pain in Guillain-Barré syndrome (English)

1 reference

30 June 2019

main subject

Guillain–Barré syndrome

0 references

1 reference

Jia Liu

1

Jia

Liu

1 reference

30 June 2019

Lu-Ning Wang

series ordinal

2

author given names

Lu-Ning

author last names

Wang

1 reference

30 June 2019

Ewan D McNicol

series ordinal

3

author given names

Ewan D

author last names

McNicol

1 reference

30 June 2019

publication date

9 April 2015

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

issue

4

1 reference

30 June 2019

page(s)

CD009950

1 reference

30 June 2019

Gabapentin for the treatment of pain in guillain-barré syndrome: a double-blinded, placebo-controlled, crossover study

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Impairment in Guillain-Barré syndrome during the first 2 years after onset: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Intravenously Administered Immunoglobulin in the Treatment of Childhood Guillain-Barre Syndrome: A Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Capsaicin for the treatment of pain in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

"Effect of pranayama and meditation as an add-on therapy in rehabilitation of patients with Guillain-Barré syndrome--a randomized control pilot study".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Carbamezapine for pain management in Guillain-Barré syndrome patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Assessment of current diagnostic criteria for Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Gabapentin in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Supportive care for patients with Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Amitriptyline for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Pain in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Pain in the Guillain-Barré syndrome: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Pain in Guillain-Barre syndrome: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Antidepressant and anticonvulsant medication for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

21 January 2018

Opioids in anesthesia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Pharmacological treatment for pain in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009950.PUB3

Glycosphingolipid antibodies in serum in patients with sciatica

21 January 2018

1 reference

12 December 2020

Opioid analgesics and the burning pain of Guillain-Barré syndrome

1 reference

12 December 2020

Pharmacological treatment for pain in Guillain-Barré syndrome

1 reference

12 December 2020

Antidepressants as analgesics: an overview of central and peripheral mechanisms of action

1 reference

12 December 2020

Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

10.1002/14651858.CD009950.PUB3

Identifiers

DOI

1 reference

30 June 2019

release_gp6x3wi5pfcpvjw2h37fevf3hq

Fatcat ID

0 references

PMC publication ID

6361619

1 reference

30 June 2019

PubMed publication ID

25855461

1 reference

30 June 2019